yeah, who cares about users numbers if you can double your expected earnings just think how much money you can make when you get more users.
They can not believe they can buy back their stock at such low prices, I bet they will be buying like crazy today and tomorrow. It will rise again. They would not be buying back their stock and paying a dividend if they didn't think their future is BRIGHT
sold 300 at $8.88 on the way down then bought 350 at $7.54 for the same amount of money as I sold the 300. So I have an extra 50 shares for this ride up.
you are an idiot. This went straight up from $2.75 to $9.00 in 8 weeks and now it pulls back a little and you are upset. It will rise again but it has to take a breather. Nothing goes straight up. Sounds like you came late to the party. Go to another board, we don't want you.
this will never reach $100 they themselves just cut their earning a lot by making a deal with ESRX. Cutting the price means cutting the profits. It is as simple as that.
but the ABBV price is $83,000 except to ESRX which isn't much cheaper. Don't you think all the others will want the lower price too and ABBV won't make any money. LOL
because they are not going to make as much on their drug as they thought because they had to make this deal with ESRX to get their drugs prescribed.
You would never ramp up production enough before it was approved, enough to supply every pharmacy in the country. Do you know how many pills that is? This company could not afford the risk.
Sovaldi, which was approved late last year, costs $84,000 for a course of treatment. AbbVie has said the shortest approved course of therapy for Viekira, 12 weeks, will cost about $83,320 at wholesale prices. The only reason esrx is going with them is for the discount. Now that there is competition Gild will discount their drug also. ABBV's price normally is only a few $100's cheaper and you have to take 6 pills a day instead of 1. I don't think many doctors are going to switch.
Are they going to have this ready for launch Jan. 1? It will be pretty bad if they cut Gild out Jan 1 and their patients can't even get ABBV's drug because they don't have enough in production by then. Or worse start people's regimen and then don't have pills for the refills.